4/A: Centene CFO Amends Ownership, Details New Equity Awards

Centene's Chief Financial Officer, Andrew Lynn Asher, filed an amended Form 4 detailing new equity awards and adjusting previous holdings due to unvested performance units.

Summary

• Andrew Lynn Asher, Centene's Chief Financial Officer, filed an amended Form 4 (Form 4/A) to correct his beneficial ownership statement.
• The amendment removed 67,985 unvested performance stock units from his total holdings, as these units did not meet the vesting criteria for the performance period ending December 31, 2025, as determined on January 26, 2026.
• On January 26, 2026, Asher was granted 173,573 shares of common stock as a new equity award.
• This new award includes 69,429 restricted stock units (RSUs) that will vest in three annual installments, with the first installment beginning on March 15, 2027.
• The award also includes 104,144 performance stock units (PSUs) reported at target level performance, with actual vesting on March 15, 2029, contingent on the company's stock price performance between late 2025 and late 2028.
• Following these reported transactions, Asher's total beneficial ownership stands at 763,230.48 shares, which includes 316,262 shares from previously-granted restricted stock units and performance stock units (at target level) that are still subject to vesting requirements.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral to slightly negative. While new equity awards are positive for incentive alignment, the non-vesting of a significant number of previous performance units indicates unmet targets, which is a concern.

Positives

• Grant of 173,573 new equity awards to the Chief Financial Officer, which aligns management incentives with long-term shareholder interests.
• The new performance stock units are tied to the company's stock price performance, incentivizing the CFO to drive long-term value creation.

Negatives

• 67,985 performance stock units from a previous award did not meet vesting criteria for the period ending December 31, 2025, indicating that certain performance targets were not achieved.

Risks

• The actual number of performance stock units that will vest from the new award can range from 0% to 200% of the reported target based on the company's stock price performance, introducing variability in executive compensation.
• The non-vesting of previous performance units highlights the inherent risk in performance-based compensation if specific targets are not met.

Future Outlook

The new performance stock units granted to the CFO are tied to the company's stock price performance between the final 20 trading days of 2025 and the final 60 trading days of 2028, indicating a long-term incentive structure focused on shareholder value creation over several years.

Industry Context

StockSavvy.ai notes that executive compensation, particularly through equity awards like RSUs and PSUs, is a standard practice in the healthcare insurance industry to align executive interests with long-term company performance and shareholder returns. The use of performance-based units tied to stock price performance is a common mechanism to incentivize value creation and is widely adopted by peers.

Comparison to Industry Standards

• The structure of equity awards, including both time-based RSUs and performance-based PSUs, is consistent with compensation practices observed at peer companies in the managed care sector such as UnitedHealth Group (UNH) and Elevance Health (ELV).
• The non-vesting of 67,985 PSUs due to unmet performance criteria demonstrates a functioning performance-based compensation system, which is a positive sign for corporate governance compared to companies where performance targets are consistently met without significant challenge.

Corporate Governance

Stakeholder Impact

• Shareholders: The non-vesting of previous PSUs indicates that certain performance targets were not met, which could be a minor concern. However, the new performance-based awards align the CFO's incentives with long-term stock price performance, potentially benefiting shareholders.
• Employees: No direct impact mentioned for general employees.

Next Steps

• First annual vesting installment of 69,429 restricted stock units on March 15, 2027.
• Vesting determination for 104,144 performance stock units on March 15, 2029, based on stock price performance.

Key Dates

Recommendation

This filing primarily details executive compensation adjustments and new equity grants, which are routine for a public company. While the non-vesting of some performance units is a minor negative, the overall impact on the company's fundamental value or strategic direction is limited. The new performance-based awards align management incentives, which is generally positive. A seasoned investor would likely maintain their current position based solely on this administrative filing.

Keywords

Centene, CNC, Form 4/A, Insider Trading, Beneficial Ownership, Restricted Stock Units, Performance Stock Units, Executive Compensation, Andrew Lynn Asher, CFO